<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="bold;} span.year {font-family : courier ; font-style : italic;} Eur" exact="Heart" post="J SupplEur Heart J SupplehjsuppEuropean Heart Journal Supplements :"/>
 <result pre=": courier ; font-style : italic;} Eur Heart J SupplEur" exact="Heart" post="J SupplehjsuppEuropean Heart Journal Supplements : Journal of the"/>
 <result pre="font-style : italic;} Eur Heart J SupplEur Heart J SupplehjsuppEuropean" exact="Heart" post="Journal Supplements : Journal of the European Society of"/>
 <result pre="pmcid: 7270913 doi: 10.1093/eurheartj/suaa064suaa064 : Articles Causal relationship between influenza" exact="infection" post="and risk of acute myocardial infarction: pathophysiological hypothesis and"/>
 <result pre=": Articles Causal relationship between influenza infection and risk of" exact="acute" post="myocardial infarction: pathophysiological hypothesis and clinical implications MuscenteFrancescas1De CaterinaRaffaeles2[s1],"/>
 <result pre="journals.permissions@oup.comsuaa064.pdf Abstract Abstract Presently several evidences support an association between" exact="acute" post="myocardial infarction and influenza infection. The pathophysiology rationale rests"/>
 <result pre="Abstract Abstract Presently several evidences support an association between acute" exact="myocardial infarction" post="and influenza infection. The pathophysiology rationale rests on the"/>
 <result pre="observational evidences support a potential role of influenza vaccine in" exact="cardiovascular" post="prevention. It is estimated that the efficacy of influenza"/>
 <result pre="is estimated that the efficacy of influenza vaccine in preventing" exact="myocardial infarction" post="could range between 15% and 45%. Notwithstanding the clear"/>
 <result pre="Notwithstanding the clear recommendation of numerous guidelines concerning patients with" exact="cardiovascular" post="diseases, vaccination rates are still low in the high-risk"/>
 <result pre="in the high-risk groups. Influenza vaccine as preventive measure of" exact="cardiovascular disease" post="still awaits support from randomized clinical trials. Nonetheless, considering"/>
 <result pre="the high-risk groups. Influenza vaccine as preventive measure of cardiovascular" exact="disease" post="still awaits support from randomized clinical trials. Nonetheless, considering"/>
 <result pre="should be encouraged in everyday clinical practice. Myocardial infarction Influenza" exact="infection" post="Plaque rupture Influenza vaccine Acute coronary syndrome page-count: Introduction"/>
 <result pre="clinical practice. Myocardial infarction Influenza infection Plaque rupture Influenza vaccine" exact="Acute" post="coronary syndrome page-count: Introduction Although several studies have analysed"/>
 <result pre="Myocardial infarction Influenza infection Plaque rupture Influenza vaccine Acute coronary" exact="syndrome" post="page-count: Introduction Although several studies have analysed the association"/>
 <result pre="several studies have analysed the association between various types of" exact="infection" post="and acute cardio and cerebrovascular events, convincing evidence of"/>
 <result pre="have analysed the association between various types of infection and" exact="acute" post="cardio and cerebrovascular events, convincing evidence of a stronger"/>
 <result pre="has emerged for the flu syndrome. The epidemiological relationship between" exact="acute" post="myocardial infarction (AMI) and flu syndrome was first observed"/>
 <result pre="emerged for the flu syndrome. The epidemiological relationship between acute" exact="myocardial infarction" post="(AMI) and flu syndrome was first observed in 1930"/>
 <result pre="The epidemiological relationship between acute myocardial infarction (AMI) and flu" exact="syndrome" post="was first observed in 1930 with an increased mortality"/>
 <result pre="first observed in 1930 with an increased mortality due to" exact="cardiovascular" post="causes in conjunction with the epidemic influenza peak.1 To"/>
 <result pre="we will, therefore, examine the possible causal link between influenza" exact="infection" post="and AMI. In general, the search for a causal"/>
 <result pre="hypothesize the existence of a true causal relationship between flu" exact="syndrome" post="and acute coronary syndrome (ACS). Arguing this causality is,"/>
 <result pre="existence of a true causal relationship between flu syndrome and" exact="acute" post="coronary syndrome (ACS). Arguing this causality is, moreover, not"/>
 <result pre="a true causal relationship between flu syndrome and acute coronary" exact="syndrome" post="(ACS). Arguing this causality is, moreover, not an intellectual"/>
 <result pre="in the clinical setting as a means to provide further" exact="cardiovascular" post="prevention through the systematic use of vaccination. Epidemiological evidence"/>
 <result pre="Several studies have shown the existence of an association between" exact="respiratory" post="infections and the development of AMI. However, in many"/>
 <result pre="studies have shown the existence of an association between respiratory" exact="infections" post="and the development of AMI. However, in many of"/>
 <result pre="AMI. However, in many of them, the clinical diagnosis of" exact="infectious disease" post="was neither sensitive nor specific for the confirmation of"/>
 <result pre="However, in many of them, the clinical diagnosis of infectious" exact="disease" post="was neither sensitive nor specific for the confirmation of"/>
 <result pre="was neither sensitive nor specific for the confirmation of influenza" exact="virus infection." post="In this regard, Smeeth et al.,3 Who had included"/>
 <result pre="et al.,3 Who had included 20 486 subjects with a first" exact="myocardial infarction" post="and 19 063 subjects with a first acute cerebrovascular event"/>
 <result pre="a first myocardial infarction and 19 063 subjects with a first" exact="acute" post="cerebrovascular event had shown that the risk for both"/>
 <result pre="both events was higher within the first 3 days from an" exact="acute" post="respiratory infection; the incidence ratio for myocardial infarction was"/>
 <result pre="events was higher within the first 3 days from an acute" exact="respiratory" post="infection; the incidence ratio for myocardial infarction was 4.95"/>
 <result pre="3 days from an acute respiratory infection; the incidence ratio for" exact="myocardial infarction" post="was 4.95 [95% confidence interval (CI): 4.43–5.53] and the"/>
 <result pre="infarction was 4.95 [95% confidence interval (CI): 4.43–5.53] and the" exact="stroke" post="rate of 3.19 (95% CI: 2.81–3.62). More recently, Warren-Gash"/>
 <result pre="11 208 subjects hospitalized for ACS, of which 3927 with recent" exact="acute" post="respiratory infection. They showed a significantly higher risk of"/>
 <result pre="subjects hospitalized for ACS, of which 3927 with recent acute" exact="respiratory" post="infection. They showed a significantly higher risk of AMI"/>
 <result pre="significantly higher risk of AMI during the first 3 days of" exact="acute" post="respiratory infection, with an incidence ratio of 4.19 (95%"/>
 <result pre="higher risk of AMI during the first 3 days of acute" exact="respiratory" post="infection, with an incidence ratio of 4.19 (95% CI:"/>
 <result pre="in risk over time. Among other things, it emerged that" exact="infections" post="occurring during the influenza epidemic and those coded as"/>
 <result pre="are evidences deriving from case–control studies which, as such, are" exact="limited" post="by defects (bias) of selection, confounding factors, and reduced"/>
 <result pre="1980, Pönkä et al.5 conducted a case–control study including a" exact="total" post="of 49 patients with myocardial infarction (MI) subjected to"/>
 <result pre="a case–control study including a total of 49 patients with" exact="myocardial infarction" post="(MI) subjected to the determination of the antibody titter"/>
 <result pre="antibody titter between patients with AMI and controls. Therefore, this" exact="limited" post="series of cases did not confirm the hypothesis that"/>
 <result pre="series of cases did not confirm the hypothesis that a" exact="viral infection," post="including that with Influenza A virus, was associated with"/>
 <result pre="AMI, while the controls were ambulatory subjects without AMI. The" exact="primary" post="outcome measure was laboratory evidence of influenza infection. Of"/>
 <result pre="1.97; 95% CI: 1.09–3.54]; for statistical analysis; however, the flu" exact="infection" post="was not a significant predictor for AMI. A case–control"/>
 <result pre="study demonstrates the existence of a strong association between influenza" exact="infection" post="and AMI, it is limited by the fact that"/>
 <result pre="a strong association between influenza infection and AMI, it is" exact="limited" post="by the fact that the results derived from serological"/>
 <result pre="Medicine in January 2018, evaluated the association between laboratory-confirmed influenza" exact="infection" post="with highly specific methods and hospitalization for IMA. In"/>
 <result pre="in the first 7 days after laboratory confirmation of the influenza" exact="infection" post="compared to the control interval, and no increase in"/>
 <result pre="analysis showed that the incidence ratio was higher for more" exact="adult" post="subjects, for Type B influenza and for patients affected"/>
 <result pre="the incidence ratio was higher for more adult subjects, for" exact="Type B" post="influenza and for patients affected by a first myocardial"/>
 <result pre="Type B influenza and for patients affected by a first" exact="myocardial infarction;" post="however, these subgroup analyses did not have sufficient statistical"/>
 <result pre="differences. The incidence of AMI was still high even after" exact="infection" post="with non-influenza respiratory virus, although minor compared to the"/>
 <result pre="of AMI was still high even after infection with non-influenza" exact="respiratory" post="virus, although minor compared to the secondary forms of"/>
 <result pre="infection with non-influenza respiratory virus, although minor compared to the" exact="secondary" post="forms of influenza infection. Specifically, an incidence ratio for"/>
 <result pre="influenza infection. Specifically, an incidence ratio for AMI emerged for" exact="Type B" post="influenza (95% CI: 4.37–23.38), 5.17 for Type A influenza"/>
 <result pre="5.17 for Type A influenza (95% CI: 3.02–8.84), 3.51 for" exact="respiratory" post="syncytial virus (95% CI: 1.11–11.12), and 2.77 for other"/>
 <result pre="(95% CI: 1.23–6.24).8 According to these most recent results, therefore" exact="acute" post="respiratory infections, and in particular—but not only—the flu, would"/>
 <result pre="CI: 1.23–6.24).8 According to these most recent results, therefore acute" exact="respiratory" post="infections, and in particular—but not only—the flu, would seem"/>
 <result pre="assumptions The crucial role of inflammation in the development of" exact="acute" post="coronary syndrome (ACS) is now well known; in this"/>
 <result pre="crucial role of inflammation in the development of acute coronary" exact="syndrome" post="(ACS) is now well known; in this sense, it"/>
 <result pre="in this sense, it would not be surprising how an" exact="acute" post="infection, with all its inflammatory potential, can contribute to"/>
 <result pre="myocardial infarction.9 The physiopathological characteristics of AMI are heterogeneous; while" exact="Type 1" post="myocardial infarction is secondary to thrombosis due to rupture"/>
 <result pre="The physiopathological characteristics of AMI are heterogeneous; while Type 1" exact="myocardial infarction" post="is secondary to thrombosis due to rupture and/or plaque"/>
 <result pre="of AMI are heterogeneous; while Type 1 myocardial infarction is" exact="secondary" post="to thrombosis due to rupture and/or plaque ulceration, Type"/>
 <result pre="are heterogeneous; while Type 1 myocardial infarction is secondary to" exact="thrombosis" post="due to rupture and/or plaque ulceration, Type 2 myocardial"/>
 <result pre="is secondary to thrombosis due to rupture and/or plaque ulceration," exact="Type 2" post="myocardial infarction is defined as a myocardial necrosis secondary"/>
 <result pre="to thrombosis due to rupture and/or plaque ulceration, Type 2" exact="myocardial infarction" post="is defined as a myocardial necrosis secondary to a"/>
 <result pre="Type 2 myocardial infarction is defined as a myocardial necrosis" exact="secondary" post="to a discrepancy between oxygen supply and demand.10 Influenza"/>
 <result pre="oxygen supply and demand.10 Influenza can be clearly related to" exact="Type 2" post="myocardial infarction due to tachycardia, fever, hypoxia, and changes"/>
 <result pre="and demand.10 Influenza can be clearly related to Type 2" exact="myocardial infarction" post="due to tachycardia, fever, hypoxia, and changes in vessel"/>
 <result pre="in this case, it is the septic state, rather than" exact="coronary thrombosis," post="the underlying cause of the flu-related myocardial necrosis. However,"/>
 <result pre="atherosclerotic plaques. Following the release of inflammatory cytokines, the flu" exact="syndrome" post="can favour the triggering of a prothrombotic state, facilitating"/>
 <result pre="cytokines, the flu syndrome can favour the triggering of a" exact="prothrombotic state," post="facilitating platelet activation and endothelial dysfunction.11,12 Simultaneously, the sympathetic"/>
 <result pre="and the increased concentration of endogenous catecholamines determine a hyperdynamic" exact="cardiovascular" post="response and changes in systemic and coronary vasal tone,"/>
 <result pre="endogenous catecholamines determine a hyperdynamic cardiovascular response and changes in" exact="systemic" post="and coronary vasal tone, with consequent vasoconstriction. Coronary vasoconstriction"/>
 <result pre="facilitate their rupture.14 Influenza infection, in addition to inducing a" exact="systemic" post="inflammatory response, would appear to have a direct inflammatory"/>
 <result pre="mice, an animal model used for the study of atherosclerosis," exact="infection" post="with influenza virus induces acute inflammation, proliferation of smooth"/>
 <result pre="for the study of atherosclerosis, infection with influenza virus induces" exact="acute" post="inflammation, proliferation of smooth muscle cells, and fibrin deposition"/>
 <result pre="infection with influenza virus induces acute inflammation, proliferation of smooth" exact="muscle" post="cells, and fibrin deposition in pre-existing atherosclerotic plaques, showing"/>
 <result pre="1 The multiple pathways that can lead from a flu" exact="syndrome" post="to an acute coronary syndrome. It has been hypothesized"/>
 <result pre="pathways that can lead from a flu syndrome to an" exact="acute" post="coronary syndrome. It has been hypothesized that the flu"/>
 <result pre="acute coronary syndrome. It has been hypothesized that the flu" exact="infection" post="leads to acute myocardial infarction through the development of"/>
 <result pre="It has been hypothesized that the flu infection leads to" exact="acute" post="myocardial infarction through the development of thrombosis on pre-existing"/>
 <result pre="has been hypothesized that the flu infection leads to acute" exact="myocardial infarction" post="through the development of thrombosis on pre-existing atherosclerotic plaques."/>
 <result pre="infection leads to acute myocardial infarction through the development of" exact="thrombosis" post="on pre-existing atherosclerotic plaques. The increased systemic and coronary"/>
 <result pre="the development of thrombosis on pre-existing atherosclerotic plaques. The increased" exact="systemic" post="and coronary inflammatory state and the increased biomechanical stress"/>
 <result pre="with consequent formation of occlusive or subocclusive thrombus. Furthermore, the" exact="acute" post="infection causes tachycardia, hypoxia, fever, and changes in the"/>
 <result pre="consequent formation of occlusive or subocclusive thrombus. Furthermore, the acute" exact="infection" post="causes tachycardia, hypoxia, fever, and changes in the volume"/>
 <result pre="in the volume status. This contributes to the evolution of" exact="acute" post="coronary syndrome as it increases metabolic demand and accentuates"/>
 <result pre="volume status. This contributes to the evolution of acute coronary" exact="syndrome" post="as it increases metabolic demand and accentuates the discrepancy"/>
 <result pre="and accentuates the discrepancy between oxygen demand and supply. ACS," exact="acute" post="coronary syndrome. Influenza vaccination for secondary prevention of coronary"/>
 <result pre="demand and supply. ACS, acute coronary syndrome. Influenza vaccination for" exact="secondary" post="prevention of coronary heart disease ‘Indirect’ evidence of a"/>
 <result pre="ACS, acute coronary syndrome. Influenza vaccination for secondary prevention of" exact="coronary heart disease" post="‘Indirect’ evidence of a possible association between influenza and"/>
 <result pre="acute coronary syndrome. Influenza vaccination for secondary prevention of coronary" exact="heart" post="disease ‘Indirect’ evidence of a possible association between influenza"/>
 <result pre="coronary syndrome. Influenza vaccination for secondary prevention of coronary heart" exact="disease" post="‘Indirect’ evidence of a possible association between influenza and"/>
 <result pre="showing that influenza vaccination is effective in the prevention of" exact="ischaemic heart disease." post="This, in addition to strengthening the causality between the"/>
 <result pre="that influenza vaccination is effective in the prevention of ischaemic" exact="heart" post="disease. This, in addition to strengthening the causality between"/>
 <result pre="protective efficacy of influenza vaccination from new coronary events in" exact="secondary" post="prevention is between 19% and 45%.6 This is a"/>
 <result pre="range of effectiveness substantially similar to that obtained with other" exact="cardiovascular" post="prevention measures widely accepted in clinical practice, including the"/>
 <result pre="the association between influenza vaccination and occurrence of AMI. A" exact="total" post="of eight studies were identified in which the cases"/>
 <result pre="in which the cases were subjects with first MI or" exact="recurrent" post="MI. The results showed a protective efficacy of influenza"/>
 <result pre="the influenza vaccine against cardiac events in subjects with pre-existing" exact="cardiovascular disease," post="the FLU vaccination in ACSs and planned percutaneous coronary"/>
 <result pre="percutaneous coronary interventions (FLUVACS)18 and the influence vaccination study in" exact="secondary" post="prevention from coronary ischaemic events in coronary artery disease"/>
 <result pre="vaccination study in secondary prevention from coronary ischaemic events in" exact="coronary artery disease" post="(FLUCAD).19 The FLUVACS, published in 2003, was a randomized,"/>
 <result pre="study in secondary prevention from coronary ischaemic events in coronary" exact="artery disease" post="(FLUCAD).19 The FLUVACS, published in 2003, was a randomized,"/>
 <result pre="in secondary prevention from coronary ischaemic events in coronary artery" exact="disease" post="(FLUCAD).19 The FLUVACS, published in 2003, was a randomized,"/>
 <result pre="to test the potential beneficial effect of influenza vaccination in" exact="secondary" post="prevention. Two hundred patients hospitalized for myocardial infarction were"/>
 <result pre="influenza vaccination in secondary prevention. Two hundred patients hospitalized for" exact="myocardial infarction" post="were enrolled within 72 h of the event and 101"/>
 <result pre="or placebo vaccination. In the intention to treat analysis, the" exact="primary" post="outcome measure, i.e. the incidence of cardiovascular death at"/>
 <result pre="treat analysis, the primary outcome measure, i.e. the incidence of" exact="cardiovascular" post="death at 1 year, was significantly lower among patients"/>
 <result pre="the incidence of cardiovascular death at 1 year, was significantly" exact="lower" post="among patients receiving vaccination than in the control group"/>
 <result pre="which 658 patients were already in optimal medical therapy for" exact="cardiovascular disease" post="were contrasting. In it, 325 subjects received influenza vaccine"/>
 <result pre="658 patients were already in optimal medical therapy for cardiovascular" exact="disease" post="were contrasting. In it, 325 subjects received influenza vaccine"/>
 <result pre="placebo. The average follow-up was 298 days. With regard to the" exact="primary" post="outcome measure of cardiovascular death, the results showed no"/>
 <result pre="was 298 days. With regard to the primary outcome measure of" exact="cardiovascular" post="death, the results showed no statistically significant differences between"/>
 <result pre="0.15–7.56, P = 0.95). However, the authors showed a tendency to the" exact="lower" post="incidence of the composite outcome measure of cardiovascular death,"/>
 <result pre="to the lower incidence of the composite outcome measure of" exact="cardiovascular" post="death, myocardial infarction, and coronary revascularization (major adverse cardiac"/>
 <result pre="lower incidence of the composite outcome measure of cardiovascular death," exact="myocardial infarction," post="and coronary revascularization (major adverse cardiac event, MACE) although"/>
 <result pre="composite outcome measure of MACE occurrence or hospitalizations due to" exact="ischaemia" post="compared to the placebo group.19 In a meta-analysis of"/>
 <result pre="a beneficial effect of influenza vaccination in the prevention of" exact="cardiovascular disease," post="few studies have been conducted to explain the possible"/>
 <result pre="association, as some data, although observational, show that the flu" exact="syndrome" post="is associated with an increased risk of ACS; this"/>
 <result pre="associated with an increased risk of ACS; this increase is" exact="transient" post="and higher in the first days after infection; therefore,"/>
 <result pre="both show a similar pathophysiology in the immune, coagulation, and" exact="vascular" post="systems. There is a principle of analogy, according to"/>
 <result pre="systems. There is a principle of analogy, according to which" exact="acute" post="infections can trigger other vascular events, such as stroke"/>
 <result pre="There is a principle of analogy, according to which acute" exact="infections" post="can trigger other vascular events, such as stroke similar"/>
 <result pre="of analogy, according to which acute infections can trigger other" exact="vascular" post="events, such as stroke similar to ACS and, analogously,"/>
 <result pre="which acute infections can trigger other vascular events, such as" exact="stroke" post="similar to ACS and, analogously, ACS can be triggered"/>
 <result pre="in other already widely accepted causal relationships, such as tobacco" exact="consumption" post="and development of lung tumour. Therefore, in light of"/>
 <result pre="of a biological gradient between type and severity of an" exact="infection" post="and ACS risk, specific data to report to the"/>
 <result pre="and ACS risk, specific data to report to the flu" exact="syndrome" post="are lacking. For example, the risk of myocardial infarction"/>
 <result pre="the flu syndrome are lacking. For example, the risk of" exact="myocardial infarction" post="would be greater after lower respiratory tract infections rather"/>
 <result pre="example, the risk of myocardial infarction would be greater after" exact="lower" post="respiratory tract infections rather than after urinary tract infection."/>
 <result pre="the risk of myocardial infarction would be greater after lower" exact="respiratory" post="tract infections rather than after urinary tract infection. Furthermore,"/>
 <result pre="of myocardial infarction would be greater after lower respiratory tract" exact="infections" post="rather than after urinary tract infection. Furthermore, in pneumococcal"/>
 <result pre="be greater after lower respiratory tract infections rather than after" exact="urinary tract infection." post="Furthermore, in pneumococcal infections, the more severe the infection"/>
 <result pre="tract infection. Furthermore, in pneumococcal infections, the more severe the" exact="infection" post="would be, the higher the risk of ACS would"/>
 <result pre="Conclusions The large number of published papers suggests that various" exact="viral" post="and bacterial infections, acute or chronic, may be associated"/>
 <result pre="large number of published papers suggests that various viral and" exact="bacterial infections," post="acute or chronic, may be associated with an increased"/>
 <result pre="of published papers suggests that various viral and bacterial infections," exact="acute" post="or chronic, may be associated with an increased risk"/>
 <result pre="published papers suggests that various viral and bacterial infections, acute" exact="or chronic," post="may be associated with an increased risk of AMI."/>
 <result pre="the one hand, influenza is one of the most frequent" exact="respiratory" post="infections, on the other, it is the only respiratory"/>
 <result pre="frequent respiratory infections, on the other, it is the only" exact="respiratory" post="virus for which it is possible to achieve effective"/>
 <result pre="be considered an absolutely necessary and sufficient causal element. Therefore," exact="acute" post="infection must be seen as a component of a"/>
 <result pre="considered an absolutely necessary and sufficient causal element. Therefore, acute" exact="infection" post="must be seen as a component of a set"/>
 <result pre="support the role of influenza vaccination for the prevention of" exact="ischaemic heart disease," post="vaccination is not considered a priority preventive measure in"/>
 <result pre="the role of influenza vaccination for the prevention of ischaemic" exact="heart" post="disease, vaccination is not considered a priority preventive measure"/>
 <result pre="still encouraged to use vaccination as a preventive measure against" exact="ischaemic heart disease," post="considering its favourable cost-effectiveness and safety profile. In the"/>
 <result pre="encouraged to use vaccination as a preventive measure against ischaemic" exact="heart" post="disease, considering its favourable cost-effectiveness and safety profile. In"/>
 <result pre="sees influenza vaccination as a simple preventive measure against the" exact="infectious" post="situation only, rather than an additional cardiovascular preventive strategy."/>
 <result pre="measure against the infectious situation only, rather than an additional" exact="cardiovascular" post="preventive strategy. Conflict of interest: none declared. References References"/>
 <result pre="causation?Proc R Soc Med1965;58:295–300.14283879 3SmeethL, ThomasSL, HallAJ, et al.Risk of" exact="myocardial infarction" post="and stroke after acute infection or vaccination. N Engl"/>
 <result pre="Med1965;58:295–300.14283879 3SmeethL, ThomasSL, HallAJ, et al.Risk of myocardial infarction and" exact="stroke" post="after acute infection or vaccination. N Engl J Med2004;351:2611–2618.15602021"/>
 <result pre="ThomasSL, HallAJ, et al.Risk of myocardial infarction and stroke after" exact="acute" post="infection or vaccination. N Engl J Med2004;351:2611–2618.15602021 4Warren-GashC, SmeethL,"/>
 <result pre="HallAJ, et al.Risk of myocardial infarction and stroke after acute" exact="infection" post="or vaccination. N Engl J Med2004;351:2611–2618.15602021 4Warren-GashC, SmeethL, HaywardAC.Influenza"/>
 <result pre="Engl J Med2004;351:2611–2618.15602021 4Warren-GashC, SmeethL, HaywardAC.Influenza as a trigger for" exact="acute" post="myocardial infarction or death from cardiovascular disease: a systematic"/>
 <result pre="J Med2004;351:2611–2618.15602021 4Warren-GashC, SmeethL, HaywardAC.Influenza as a trigger for acute" exact="myocardial infarction" post="or death from cardiovascular disease: a systematic review. Lancet"/>
 <result pre="as a trigger for acute myocardial infarction or death from" exact="cardiovascular" post="disease: a systematic review. Lancet Infect Dis2009;9:601–610.19778762 5PönkäA, JalankoH,"/>
 <result pre="5PönkäA, JalankoH, PönkäT, StenvikM.Viral and mycoplasmal antibodies in patients with" exact="myocardial infarction." post="Ann Clin Res1981;13:429–432.6814338 6MacintyreCR, HeywoodAE, KovoorP, et al.Ischaemic heart"/>
 <result pre="myocardial infarction. Ann Clin Res1981;13:429–432.6814338 6MacintyreCR, HeywoodAE, KovoorP, et al.Ischaemic" exact="heart" post="disease, influenza and influenza vaccination: a prospective case control"/>
 <result pre="control study. Heart2013;99:1843–1848.23966030 7GuanX, YangW, SunX, et al.Association of influenza" exact="virus infection" post="and inflammatory cytokines with acute myocardial infarction. Inflamm Res2012;61:591–598.22373653"/>
 <result pre="study. Heart2013;99:1843–1848.23966030 7GuanX, YangW, SunX, et al.Association of influenza virus" exact="infection" post="and inflammatory cytokines with acute myocardial infarction. Inflamm Res2012;61:591–598.22373653"/>
 <result pre="et al.Association of influenza virus infection and inflammatory cytokines with" exact="acute" post="myocardial infarction. Inflamm Res2012;61:591–598.22373653 8KwongJC, SchwartzKL, CampitelliMA, et al.Acute"/>
 <result pre="al.Association of influenza virus infection and inflammatory cytokines with acute" exact="myocardial infarction." post="Inflamm Res2012;61:591–598.22373653 8KwongJC, SchwartzKL, CampitelliMA, et al.Acute myocardial infarction"/>
 <result pre="acute myocardial infarction. Inflamm Res2012;61:591–598.22373653 8KwongJC, SchwartzKL, CampitelliMA, et al.Acute" exact="myocardial infarction" post="after laboratory-confirmed influenza infection. N Engl J Med2018;378:345–353.29365305 9Corrales-MedinaVF,"/>
 <result pre="influenza infection. N Engl J Med2018;378:345–353.29365305 9Corrales-MedinaVF, MadjidM, MusherDM.Role of" exact="acute" post="infection in triggering acute coronary syndromes. Lancet Infect Dis2010;10:83–92.20113977"/>
 <result pre="infection. N Engl J Med2018;378:345–353.29365305 9Corrales-MedinaVF, MadjidM, MusherDM.Role of acute" exact="infection" post="in triggering acute coronary syndromes. Lancet Infect Dis2010;10:83–92.20113977 10ThygesenK,"/>
 <result pre="J Med2018;378:345–353.29365305 9Corrales-MedinaVF, MadjidM, MusherDM.Role of acute infection in triggering" exact="acute" post="coronary syndromes. Lancet Infect Dis2010;10:83–92.20113977 10ThygesenK, AlpertJS, JaffeAS, et"/>
 <result pre="Infect Dis2010;10:83–92.20113977 10ThygesenK, AlpertJS, JaffeAS, et al.Fourth universal definition of" exact="myocardial infarction" post="(2018). Eur Heart J2018. 11VallanceP, CollierJ, BhagatK.Infection, inflammation, and"/>
 <result pre="JaffeAS, et al.Fourth universal definition of myocardial infarction (2018). Eur" exact="Heart" post="J2018. 11VallanceP, CollierJ, BhagatK.Infection, inflammation, and infarction: does acute"/>
 <result pre="Eur Heart J2018. 11VallanceP, CollierJ, BhagatK.Infection, inflammation, and infarction: does" exact="acute" post="endothelial dysfunction provide a link?Lancet1997;349:1391–1392.9149715 12LeviM, KellerTT, van GorpE,"/>
 <result pre="vulnerable plaque. J Am Coll Cardiol2006;47:C13–C18.16631505 15Bermudez-FajardoA, Oviedo-OrtaE.Influenza vaccination promotes" exact="stable" post="atherosclerotic plaques in apoE knockout mice. Atherosclerosis2011;217:97–105.21507404 16MacIntyreCR, MahimboA,"/>
 <result pre="et al.Influenza vaccine as a coronary intervention for prevention of" exact="myocardial infarction." post="Heart2016;102:1953–1956.27686519 17BarnesM, HeywoodAE, MahimboA, et al.Acute myocardial infarction and"/>
 <result pre="prevention of myocardial infarction. Heart2016;102:1953–1956.27686519 17BarnesM, HeywoodAE, MahimboA, et al.Acute" exact="myocardial infarction" post="and influenza: a meta-analysis of case-control studies. Heart2015;101:1738–1747.26310262 18GurfinkelEP,"/>
 <result pre="studies. Heart2015;101:1738–1747.26310262 18GurfinkelEP, Leonde, laFR, MendizO, et al.Flu vaccination in" exact="acute" post="coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study."/>
 <result pre="coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur" exact="Heart" post="J2004;25:25–31.14683739 19CiszewskiA, BilinskaZT, BrydakLB, et al.Influenza vaccination in secondary"/>
 <result pre="Eur Heart J2004;25:25–31.14683739 19CiszewskiA, BilinskaZT, BrydakLB, et al.Influenza vaccination in" exact="secondary" post="prevention from coronary ischaemic events in coronary artery disease:"/>
 <result pre="coronary ischaemic events in coronary artery disease: FLUCAD study. Eur" exact="Heart" post="J2008;29:1350–1358.18187561 20VeljkovicV, GlisicS, VeljkovicN, et al.Influenza vaccine as prevention"/>
 <result pre="J2008;29:1350–1358.18187561 20VeljkovicV, GlisicS, VeljkovicN, et al.Influenza vaccine as prevention for" exact="cardiovascular" post="diseases: possible molecular mechanism. Vaccine2014;32:6569–6575.25045818"/>
</results>
